Just another Network site

Pfizer to Acquire Anacor Pharmaceuticals for $5.2 Billion

  • Pfizer will acquire Anacor Pharmaceuticals for $5.2 billion, the companies announced Monday.
  • Over the last few years, Pfizer had been trying to make big bets overseas in an effort to become more competitive and lower its tax bill.
  • The company said the transaction would be slightly dilutive to earnings per share in 2017 and accretive the following year.

Read the full article, click here.


@Pharmaceutical: “Pfizer to Acquire Anacor Pharmaceuticals for $5.2 Billion: After terminating deals with AstraZeneca and most …”


After terminating deals with AstraZeneca and most recently, Allergan, Pfizer has turned to relatively smaller biotech companies for acquisitions.


Pfizer to Acquire Anacor Pharmaceuticals for $5.2 Billion

Comments are closed, but trackbacks and pingbacks are open.